Responses
Immune cell therapies and immune cell engineering
Original research
Armored TGFβRIIDN ROR1-CAR T cells reject solid tumors and resist suppression by constitutively-expressed and treatment-induced TGFβ1
Compose a Response to This Article
Other responses
No responses have been published for this article.
